Management of Sepsis: Early Resuscitation

Clinics in Chest Medicine

Volumn 29, Issue 4, 2008, Pages 689-704

  Rivers, Emanuel P ^a   Coba, Victor ^a   Visbal, Alvaro ^a   Whitmill, Melissa ^a   Amponsah, David ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Early goal directed therapy; Fluids; Inotropes; Resuscitation; Sepsis; Vasopressor

Indexed keywords

ADRENALIN; ALBUMIN; DEXTRAN; DIGOXIN; DOBUTAMINE; DOPAMINE; DROTRECOGIN; EPHEDRINE; GELATIN; GLYCERYL TRINITRATE; HETASTARCH; INOTROPIC AGENT; LEVOSIMENDAN; MILRINONE; NORADRENALIN; PHENYLEPHRINE; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; VASOPRESSIN;

COLLOID; CONTINUOUS INFUSION; CRYSTALLOID; DISEASE COURSE; EARLY DIAGNOSIS; EARLY INTERVENTION; FLUID RESUSCITATION; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HIGH RISK PATIENT; HUMAN; HYPOTENSION; INTENSIVE CARE; LOADING DRUG DOSE; LOW DRUG DOSE; MONOTHERAPY; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SIDE EFFECT; TACHYCARDIA; TREATMENT OUTCOME;

CALCITONIN; CRITICAL CARE; HEMODYNAMICS; HUMANS; LACTIC ACID; MULTIPLE ORGAN FAILURE; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROTEIN PRECURSORS; RESUSCITATION; SEPSIS; SHOCK, SEPTIC; SURVIVAL RATE; TROPONIN;

EID: 54049155793     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.06.005     Document Type: Review

References (107)

1. Kern J.W., and Shoemaker W.C. Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med 30 8 (2002) 1686-1692
2. Engoren M. The effect of prompt physician visits on intensive care unit mortality and cost. Crit Care Med 33 4 (2005) 727-732
3. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 6 (2006) 1589-1596
4. Lundberg J.S., Perl T.M., Wiblin T., et al. Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med 26 6 (1998) 1020-1024
5. Nguyen H.B., Rivers E.P., Knoblich B.P., et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 32 8 (2004) 1637-1642
6. Varpula M., Tallgren M., Saukkonen K., et al. Hemodynamic variables related to outcome in septic shock. Intensive Care Med 31 (2005) 1066-1071
7. Rivers E.P., Kruse J.A., Jacobsen G., et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 35 9 (2007) 2016-2024
8. Wang H.E., Shapiro N.I., Angus D.C., et al. National estimates of severe sepsis in United States emergency departments. Crit Care Med 35 8 (2007) 1928-1936
9. Rivers E.P., Coba V., and Whitmill M. Early goal-directed therapy in severe sepsis and septic shock: a contemporary review of the literature. Volume therapy and innate immune response during systemic inflammation or sepsis. Curr Opin Anaesthesiol 21 (2008) 128-140
10. Astiz M.E., Rackow E.C., and Weil M.H. Oxygen delivery and utilization during rapidly fatal septic shock in rats. Circ Shock 20 4 (1986) 281-290
11. Rady M.Y., Rivers E.P., and Nowak R.M. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. Am J Emerg Med 14 2 (1996) 218-225
12. Brun-Buisson C., Doyon F., Carlet J., et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU group for severe sepsis. J Am Med Assoc 274 12 (1995) 968-974
13. Vincent J.L., and De Backer D. Oxygen uptake/oxygen supply dependency: fact or fiction?. Acta Anaesthesiol Scand Suppl 107 (1995) 229-237
14. Parrillo J.E., Parker M.M., Natanson C., et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. [see comments]. Ann Intern Med 113 3 (1990) 227-242
15. Silance P.G., and Vincent J.L. Oxygen extraction in patients with sepsis and heart failure: another look at clinical studies. Clin Intensive Care 5 1 (1994) 4-14
16. Astiz M.E., Rackow E.C., Kaufman B., et al. Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med 16 7 (1988) 655-658
17. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 19 (2001) 1368-1377
18. Aduen J., Bernstein W.K., Khastgir T., et al. The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. J Am Med Assoc 272 21 (1994) 1678-1685
19. Broder G., and Weil M.H. Excess lactate: an index of reversibility of shock in human patients. Science 143 (1964) 1457-1459
20. Cady Jr. L.D., Weil M.H., Afifi A.A., et al. Quantitation of severity of critical illness with special reference to blood lactate. Crit Care Med 1 2 (1973) 75-80
21. Shapiro N.I., Howell M.D., Talmor D., et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 45 5 (2005) 524-528
22. Middleton P., Kelly A.M., Brown J., et al. Agreement between arterial and central venous values for pH, bicarbonate, base excess, and lactate. Emerg Med J 23 8 (2006) 622-624
23. Younger J.G., Falk J.L., and Rothrock S.G. Relationship between arterial and peripheral venous lactate levels. Acad Emerg Med 3 7 (1996) 730-734
24. Garcia A.J., Sherwin R.L., and Bilkovski R.N. Point-of-care lactate testing as a predictor of mortality in a heterogeneous emergency department population. Acad Emerg Med 13 5 Suppl 1 (2006) S152
25. Trzeciak S., Dellinger R.P., Chansky M.E., et al. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med 33 6 (2007) 970-977
26. Wira C., Rivers E., Donnino M., et al. Surrogate markers for lactic acidosis in patients with severe sepsis and septic shock. Crit Care Med 32 12 (2004) A151
27. James J.H., Luchette F.A., McCarter F.D., et al. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 354 9177 (1999) 505-508
28. De Backer D. Lactic acidosis. Minerva Anestesiol 69 4 (2003) 281-284
29. Maeder M., Fehr T., Rickli H., et al. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 129 5 (2006) 1349-1366
30. Rivers E.P., McCord J., Otero R., et al. Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock. J Intensive Care Med 22 6 (2007) 363-373
31. Phua J., Koay E.S., and Lee K.H. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 29 3 (2008) 328-333
32. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med 27 3 (1999) 639-660
33. Dorresteijn M.J., van Eijk L.T., Netea M.G., et al. Iso-osmolar prehydration shifts the cytokine response towards a more anti-inflammatory balance in human endotoxemia. J Endotoxin Res 11 5 (2005) 287-293
34. Packman M.I., and Rackow E.C. Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 11 3 (1983) 165-169
35. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36 1 (2008) 296-327
36. Durairaj L., and Schmidt G.A. Fluid therapy in resuscitated sepsis: less is more. Chest 133 1 (2008) 252-263
37. Shoemaker W.C. Relation of oxygen transport patterns to the pathophysiology and therapy of shock states. Intensive Care Med 13 4 (1987) 230-243
38. Vincent J.L., and Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 32 11 Suppl (2004) S451-S454
39. Rackow E.C., Falk J.L., Fein I.A., et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 11 11 (1983) 839-850
40. Barron M.E., Wilkes M.M., and Navickis R.J. A systematic review of the comparative safety of colloids. Arch Surg 139 5 (2004) 552-563
41. Evidence-based colloid use in the critically ill: American Thoracic Society consensus statement. Am J Respir Crit Care Med 170 11 (2004) 1247-1259
42. Wiedemann H.P., Wheeler A.P., Bernard G.R., et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354 24 (2006) 2564-2575
43. Estenssoro E., Gonzalez F., Laffaire E., et al. Shock on admission day is the best predictor of prolonged mechanical ventilation in the ICU. Chest 127 2 (2005) 598-603
44. Rivers E.P. Fluid-management strategies in acute lung injury-liberal, conservative, or both?. N Engl J Med (2006)
45. LeDoux D., Astiz M.E., Carpati C.M., et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28 8 (2000) 2729-2732
46. De Backer D., Creteur J., Silva E., et al. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best?. Crit Care Med 31 6 (2003) 1659-1667
47. In: Marini J.J., and Wheeler A.P. (Eds). Critical care medicine: the essentials. 3rd edition (2006), Lippincott Williams & Wilkins, Philadelphia No. 1
48. Mullner M., Urbanek B., Havel C., et al. Vasopressors for shock. Cochrane Database Syst Rev 3 (2004) CD003709
49. Levy M.M., Macias W.L., Vincent J.L., et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 33 10 (2005) 2194-2201
50. Trzeciak S., and Rivers E.P. Clinical manifestations of disordered microcirculatory perfusion in severe sepsis. Crit Care 9 Suppl 4 (2005) S20-S26
51. Cerra F.B., Hassett J., and Siegel J.H. Vasodilator therapy in clinical sepsis with low output syndrome. J Surg Res 25 2 (1978) 180-183
52. Spronk P.E., Ince C., Gardien M.J., et al. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 360 9343 (2002) 1395-1396
53. Vincent J.-L., O'Brien J., Wheeler A., et al. Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis. Critical Care 10 3 (2006) 1-10
54. Vincent J.L., Sakr Y., Sprung C., et al. Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients study. Anesthesiology 108 1 (2008) 31-39
55. Sakr Y., Chierego M., Piagnerelli M., et al. Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med (2007)
56. Heyland D.K., Cook D.J., King D., et al. Maximizing oxygen delivery in critically ill patients: a methodologic appraisal of the evidence. [see comments]. Crit Care Med 24 3 (1996) 517-524
57. De Backer D., Creteur J., Dubois M.J., et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 34 2 (2006) 403-408
58. Qiu H.B., Yang Y., Zhou S.X., et al. Prognostic value of dobutamine stress test in patients with septic shock. Acta Pharmacol Sin 22 1 (2001) 71-75
59. Rhodes A., Lamb F.J., Malagon I., et al. A prospective study of the use of a dobutamine stress test to identify outcome in patients with sepsis, severe sepsis, or septic shock. Crit Care Med 27 11 (1999) 2361-2366
60. Morelli A., De Castro S., Teboul J.L., et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31 5 (2005) 638-644
61. Nasraway S.A., Rackow E.C., Astiz M.E., et al. Inotropic response to digoxin and dopamine in patients with severe sepsis, cardiac failure, and systemic hypoperfusion. Chest 95 3 (1989) 612-615
62. Boulos M., Astiz M.E., Barua R.S., et al. Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase. Crit Care Med 31 2 (2003) 353-358
63. Karimova A., and Pinsky D.J. The endothelial response to oxygen deprivation: biology and clinical implications. Intensive Care Med 27 1 (2001) 19-31
64. Benjamin E., Leibowitz A.B., Oropello J., et al. Systemic hypoxic and inflammatory syndrome: an alternative designation for "sepsis syndrome". Crit Care Med 20 5 (1992) 680-682
65. Goodman R.B., Strieter R.M., Martin D.P., et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 154 3 Pt 1 (1996) 602-611
66. Webert K.E., and Blajchman M.A. Transfusion-related acute lung injury. Curr Opin Hematol 12 6 (2005) 480-487
67. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 10 (2001) 699-709
68. Shapiro N.I., Howell M.D., Talmor D., et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 34 4 (2006) 1025-1032
69. Trzeciak S., Dellinger R.P., Abate N.L., et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 129 2 (2006) 225-232
70. Talmor D., Greenberg D., Howell M.D., et al. The costs and cost-effectiveness of an integrated sepsis treatment protocol. Crit Care Med 36 4 (2008) 1168-1174
71. Shorr A.F., Micek S.T., Jackson Jr. W.L., et al. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?. Crit Care Med 35 5 (2007) 1257-1262
72. Frank E.D. A shock team in a general hospital. Anesth Analg 46 6 (1967) 740-745
73. Sebat F., Johnson D., Musthafa A.A., et al. A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. Chest 127 5 (2005) 1729-1743
74. Nguyen H.B., Corbett S.W., Steele R., et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 35 4 (2007) 1105-1112
75. Mullon J., Subramanian S., Haro L., et al. Sepsis order set improves adherence to evidence-based practices. Scientific highlights: abstracts of original investigations and case reports. Chest 130 4 Suppl (2006) 134S-135S
76. Becker M.L. LIFE campaign: implementation of sepsis bundle results in significant cost savings. Ann Emerg Med 50 3 (2007) S82
77. McGrath M.E., Lada P., Rebholz C.M., et al. Does introduction of a sepsis protocol reduce time to antibiotics or improve outcomes for critical septic patients? A before and after study. Ann Emerg Med 50 3 (2007) S19-S20
78. Otero R.M., Nguyen H.B., Huang D.T., et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 130 5 (2006) 1579-1595
79. Dorman T., Breslow M.J., Lipsett P.A., et al. Radial artery pressure monitoring underestimates central arterial pressure during vasopressor therapy in critically ill surgical patients. Crit Care Med 26 10 (1998) 1646-1649
80. Pinsky M.R., and Teboul J.L. Assessment of indices of preload and volume responsiveness. Curr Opin Crit Care 11 3 (2005) 235-239
81. Osman D., Ridel C., Ray P., et al. Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med 35 1 (2007) 64-68
82. Michard F., Lopes M., and Auler J.-O. Pulse pressure variation: beyond the fluid management of patients with shock. Critical Care 11 3 (2007) 131
83. Hadian M., and Pinsky M.R. Functional hemodynamic monitoring. Curr Opin Crit Care 13 3 (2007) 318-323
84. Michard F., and Teboul J.L. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest 121 6 (2002) 2000-2008
85. Reinhart K., and Bloos F. The value of venous oximetry. Curr Opin Crit Care 11 3 (2005) 259-263
86. Cuschieri J., Rivers E.P., Donnino M.W., et al. Central venous-arterial carbon dioxide difference as an indicator of cardiac index. Intensive Care Med 31 6 (2005) 818-822
87. Weil M.H., Nakagawa Y., Tang W., et al. Sublingual capnometry: a new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock. Crit Care Med 27 7 (1999) 1225-1229
88. Marik P.E. Regional carbon dioxide monitoring to assess the adequacy of tissue perfusion. Curr Opin Crit Care 11 3 (2005) 245-251
89. Beaulieu Y. Bedside echocardiography in the assessment of the critically ill. Crit Care Med 35 5 Suppl (2007) S235-S249
90. Prentice D., and Sona C. Esophageal Doppler monitoring for hemodynamic assessment. Crit Care Nurs Clin North Am 18 2 (2006) 189-193 x
91. Houtchens B.A., and Westenskow D.R. Oxygen consumption in septic shock: collective review. Circ Shock 13 4 (1984) 361-384
92. Skarda D.E., Mulier K.E., Myers D.E., et al. Dynamic near-infrared spectroscopy measurements in patients with severe sepsis. Shock 27 4 (2007) 348-353
93. Verdant C., and De Backer D. How monitoring of the microcirculation may help us at the bedside. Curr Opin Crit Care 11 3 (2005) 240-244
94. Finfer S., Bellomo R., Boyce N., et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350 22 (2004) 2247-2256
95. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358 2 (2008) 125-139
96. Wiedermann C.J. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med 8 (2008) 1-8
97. Sriskandan S., and Altmann D.M. The immunology of sepsis. J Pathol 214 2 (2008) 211-223
98. Vincent J.L., and Weil M.H. Fluid challenge revisited. Crit Care Med (2006)
99. Martin C., Viviand X., Leone M., et al. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 28 8 (2000) 2758-2765
100. Marik P.E., and Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. J Am Med Assoc 272 17 (1994) 1354-1357
101. Beale R.J., Hollenberg S.M., Vincent J.L., et al. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med 32 11 Suppl (2004) S455-S465
102. Jakob S. Clinical review: splanchnic ischaemia. Critical Care 6 4 (2002) 306-312
103. Sakr Y., Reinhart K., Vincent J.L., et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) study. Crit Care Med 34 3 (2006) 589-597
104. In: Parrillo J.E., and Dellinger R.P. (Eds). Critical care medicine: principles of diagnosis and management in the adult. 3rd edition (2008), Mosby Elsevier, Philadelphia p. 1
105. Landry D.W., Levin H.R., Gallant E.M., et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95 5 (1997) 1122-1125
106. Ertmer C., Morelli A., Bone H.G., et al. Dobutamine reverses the vasopressin-associated impairment in cardiac index and systemic oxygen supply in ovine endotoxemia. Crit Care 10 5 (2006) 1-9
107. Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358 9 (2008) 877-887